3 days popular7 days popular1 month popular3 months popular

Pitt team identifies cause of resilience to tinnitus, potential drug therapy

Researchers have identified in an animal model the molecular mechanisms behind resilience to noise-induced and a possible drug therapy that could reduce susceptibility to this chronic and sometimes debilitating condition. The findings by a team from the were published online in the journal eLife.

Tinnitus is typically induced by exposure to loud noise and causes whistling, clicking, roaring and other phantom sounds. It is estimated that 5 to 15 percent of Americans suffer from tinnitus, said , Ph.D., associate professor and member of the auditory research group in the Department of Otolaryngology, Pitt School of Medicine, where he also holds the auditory physiology endowed chair.

The study results build on previous research in mouse models demonstrating that tinnitus is associated with hyperactivity of dorsal cochlear nucleus (DCN) cells, which fire impulses even when there is no actual sound to perceive. The team’s work has shown that this hyperactivity is caused by a reduction in tiny channels, called KCNQ channels, through which potassium ions travel in and out of the cell. Based on this finding, KCNQ channel activators have emerged as clinical candidates for preventing the development of tinnitus.

“However, a significant percentage of people are exposed to loud sounds and never develop tinnitus, and there was little known about why that is. That’s what we set out to examine in this study,” Dr. Tzounopoulos said.

This newest study found that mice that are exposed to loud noise but do not develop tinnitus show a transient reduction in KCNQ2/3 , which is followed by a recovery of KCNQ2/3 activity and a reduction in hyperpolarization-activated cyclic nucleotide-gated (HCN) , another channel through which positively charged ions travel in and out of the cell.

The investigators believe a combination of drugs that enhance KCNQ2/3 channel activity and reduce HCN channel activity could promote resilience and reduce susceptibility to tinnitus.

“We have already developed novel activators of KCNQ2/3 channels. The next step, in collaboration with Dr. Peter Wipf, a medicinal chemist from the University of Pittsburgh, is to develop specific blockers of HCN channels,” Dr. Tzounopoulos said.